|
| Scientific Program |
| |
|
| Scientific Program | Search Abstract |
| |
|
|
| Session |
| |
| Myelodysplastic syndromes II |
| Date: |
Saturday, 06 June 2009
|
| Time: | 18:00-19:15 |
| Room: | |
| |
| 18:00-19:15 |
|
PROMOTER HYPERMETHYLATION STATUS OF THE MEG3 AND SNRPN IMPRINTED GENES IN MYELODYSPLASTIC SYNDROMES
| 0793 |
| Benetatos, Leonidas,
Hatzimichael, Eleftheria,
Dranitsaris, George,
Dasoula, Aggeliki,
Syrrou, Maria,
Tsiara, Stavroula,
Vartholomatos, Georgios,
Voukelatou, Maria,
Bourantas, Konstantinos
(Ioannina, Greece) |
| |
| 18:00-19:15 |
|
SERUM ERYTHROPOIETIN AT DIAGNOSIS IN LOW GRADE MYELODYSPLASTIC SYNDROME CORRELATES WITH BOTH RED CELL ZINC PROTOPORPHYRIN AND SERUM LDH AND MAY REFLECT SEVERITY OF INEFFECTIVE ERYTHROPOIESIS
| 0794 |
| Murphy, Philip,
McPherson, Suzanne,
Breen, Karen,
Slaby, Jiri
(Dublin, Ireland) |
| |
| 18:00-19:15 |
|
ANALYSIS OF EXPRESSION OF THE WNT-ANTAGONIST SFRP1 AND QUANTIFICATION OF ITS PROMOTER METHYLATION BY PYROSEQUENCING IN BONE MARROW MONONUCLEAR CELLS FROM PATIENTS WITH DIFFERENT RISK-TYPES OF MDS, ALL, AND AML
| 0795 |
| Reins, Jana ,
Mossner, Maximillian,
Kmetsch, Anke,
Platzbecker, Uwe,
Thiel, Eckhard,
Hofmann, Wolf-Karsten
(Berlin, Germany) |
| |
| 18:00-19:15 |
|
A NOVEL PEDIGREE WITH HETEROZYGOUS GERMLINE RUNX1 MUTATION CAUSING FAMILIAL MDS-RELATED AML – CAN THESE FAMILIES SERVE AS A MULTISTEP MODEL FOR LEUKAEMIC TRANSFORMATION IN MDS AND AML?
| 0796 |
| Ripperger, Tim,
Steinemann, Doris,
Göhring, Gudrun,
Niemeyer, Charlotte M.,
Strahm, Brigitte,
Schlegelberger, Brigitte
(Hannover, Germany) |
| |
| 18:00-19:15 |
|
DECREASE IN INTRA- AND EXTRA-CELLULAR FREE IRON SPECIES AND OXIDATIVE STRESS PARAMETERS AND INCREASE IN SERUM AND URINARY HEPCIDIN DURING TREATMENT WITH DEFERASIROX IN IRON-LOADED PATIENTS WITH MDS
| 0797 |
| Ghoti, Hussam,
Fibach, E.,
Merkel, D.,
Amer, J.,
Nagler, A.,
Levi, I. ,
Grisariu, S.,
Naparstek, E.,
Ackerstein, A.,
Olbina, G.,
Westerman, M.,
Ganz, T.,
Rachmilewitz, E.A.
(Holon, Israel) |
| |
| 18:00-19:15 |
|
COMPARISON OF ALTERNATIVE SPLICING OF THE RETROVIRAL RECEPTOR/HEME EXPORTER FLVCR1 IN MYELODYSPLASTIC SYNDROMES AND NORMAL ERYTHROPOIESIS WITH DIAMOND BLACKFAN ANEMIA
| 0798 |
| Steensma, David,
Porcher, Julie
(Rochester Minnesota, United States of America) |
| |
| 18:00-19:15 |
|
CD34 CELLS ARE UNDER OXIDATIVE STRESS - POSSIBLE IMPLICATION IN MDS PATHOGENESIS
| 0799 |
| Gonçalves, Ana Cristina,
Cortesão, E.,
Alves, V.,
Espadana, A. I.,
Rito, L.,
Magalhães, E.,
Pereira, S.,
Moucho, C.,
Pereira, A.,
Sousa, I.,
Teixeira, A.,
Sarmento-Ribeiro, A.B.
(Coimbra, Portugal) |
| |
| 18:00-19:15 |
|
JAK2 V617F MUTATION IN PRIMARY MYELODYSPLASTIC SYNDROMES: A MULTICENTER RETROSPECTIVE STUDY
| 0800 |
| Dahabreh, Issa,
Manola, Kalliopi,
Galanopoulos, Athanasios,
Zoi, Christine,
Giannouli, Stavroula,
Stavropoulou , Chryssa,
Vlachadami, Ioanna,
Kalderi , Themelina ,
Fisfis, Markos,
Stefanoudaki, Katy,
Terpos, Evangelos,
Gota, Vaia,
Kartasis, Zafeiris,
Palliou, Eleni ,
Katsigiannis, Andreas,
Roussou, Paraskevi,
Anagnostopoulos, Nicholas,
Lafioniatis, Stelios,
Palliou, Andrianna,
Loukopoulos, Dimitris,
Sambani, Constantina ,
Voulgarelis, Michael,
Zoi, Katerina
(Athens, Greece) |
| |
| 18:00-19:15 |
|
SUPPRESSION OF THE DNA DAMAGE RESPONSE IN ACUTE MYELOID LEUKEMIA VERSUS MYELODYSPLASTIC SYNDROME
| 0801 |
| Boehrer, Simone,
Adès, Lionel,
Gardin, Claude,
Hofmann, Wolf Karsten,
Fenaux, Pierre,
Kroemer, Guido
(Bobigny, France) |
| |
| 18:00-19:15 |
|
IMMUNE EFFECTORS AND REGULATORY T CELLS IN MYELODYSPLASTIC SYNDROMES (MDS)
| 0802 |
| Alfinito, Fiorella,
Sica, Michela,
Luciano, Luigiana,
Della Pepa, Roberta,
Palladino, Carmela,
Ferrara, Idalucia,
Giani, Umberto,
Ruggiero, Giuseppina,
Terrazzano, Giuseppe
(Naples, Italy) |
| |
| 18:00-19:15 |
|
NANOG MRNA IS HIGHLY EXPRESSED IN MDS CELLS AND DURING ERYTHROID DIFFERENTIATION
| 0803 |
| Xavier, Juliana,
Barcellos, K.S.A,
Duarte, A.S.S.,
Rego, P.B.,
Traina, F.,
Costa, F.F.,
Saad, S.T.O.
(Campinas, Brazil) |
| |
| 18:00-19:15 |
|
EXPRESSION PATTERNS OF CELL CYCLE AND DNA REPLICATION GENES DISCRIMINATE EARLY AND ADVANCED MDS
| 0804 |
| Vasikova, Alzbeta,
Belickova, Monika,
Budinska, Eva,
Cermak, Jaroslav
(Prague, Czech Republic) |
| |
| 18:00-19:15 |
|
LEUKEMIC TRANSFORMATION OF MDS PATIENTS DYSPLAYING ABNORMAL CYTOGENTICS WITHOUT DEFINITE DYSPLASIA IN BONE MARROW CELLS
| 0805 |
| Kim, Sung-Yong,
Kim, Myungshin,
Han, Kyungja,
Lee, Mark,
Min, Woo-Sung,
Lee, Jong-Wook
(Seoul, South-Korea) |
| |
| 18:00-19:15 |
|
THE USE OF IRON CHELATION THERAPY FOR TRANSFUSION DEPENDENT MYELODYSPLASTIC SYNDROME PATIENTS: A CROSS-SECTIONAL STUDY IN BELGIUM
| 0806 |
| Delforge, Michel,
Selleslag, Dominik,
Triffet, Agnès,
Mineur, Philippe,
Beguin, Yves,
Noens, Lucien,
Pluymers, Wim,
Ravoet, Christophe
(Leuven, Belgium) |
| |
| 18:00-19:15 |
|
LENALIDOMIDE TREATMENT MODULATES CELL SURFACE MOLECULE EXPRESSION AND CYTOKINE SECRETION OF HUMAN MESENCHYMAL STROMAL CELLS FROM HEALTHY DONORS AND MDS PATIENTS
| 0807 |
| Wobus, Manja,
Duennebier, Gwendolin,
Bornhaeuser, Martin,
Ehninger, Gerhard,
Platzbecker, Uwe
(Dresden, Germany) |
| |
| 18:00-19:15 |
|
INCREASE IN BONE MARROW IMMATURE NON-LYMPHOID EARLY PRECURSORS PREDICTS A SHORT SURVIVAL IN MYELODYSPLASTIC SYNDROMES
| 0808 |
| Lorand-Metze, Irene,
Reis, Suiellen,
Traina, Fabiola,
Ribeiro, Elisangela,
Saad, Sara,
Metze, Konradin
(Campinas, Brazil) |
| |
| 18:00-19:15 |
|
LINK BETWEEN OCCUPATIONAL EXPOSURE TO HEAVY METALS AND HIGH RISK MYELODYSPLASTIC SYNDROMES
| 0809 |
| Divies, Aymeric,
Hérin, Fabrice,
Delavigne , Karen,
Bart-Delabesse, Emmanuelle,
Dastugue, Nicole,
Laurent, Guy,
Adoue, Daniel,
Beyne-Rauzy, Odile
(Toulouse, France) |
| |
| 18:00-19:15 |
|
DIFFERENCES IN EXPRESSION OF GENES INVOLVED IN NUCLEAR FACTOR KAPPA B(NFKB) PATHWAY AFTER ANALYSIS BY QUANTITATIVE POLYMERASE CHAIN REACTION ARRAYS IN MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS
| 0810 |
| ROUKA, ERASMIA,
Adamidou, D,
Alexandrakis, M,
Lilakos, K,
Melidou, A,
Stathakis, N,
Kyriakou, D,
Kourelis, T
(LARISA, Greece) |
| |
| 18:00-19:15 |
|
INFLUENCE OF SERUM FERRITIN LEVELS ON OVERALL SURVIVAL IN PATIENTS WITH MYELODISPLASTIC SYNDROME
| 0811 |
| Jerez, Andrés,
Fernández, A,
Martínez, C,
Roldán , V,
Lozano, ML,
Osma, MM,
Ortuño, F,
Vicente, V
(Murcia, Spain) |
| |
| 18:00-19:15 |
|
PHOSPHOINOSITIDE-PHOSPHOLIPASE C (PI-PLC) BETA1 SIGNALLING IS INVOLVED IN ERYTHROPOIETIN RESPONSE OF LOW RISK MDS PATIENTS
| 0812 |
| Finelli, Carlo,
Follo, Matilde,
Mongiorgi, Sara,
Clissa, Cristina,
Chiarini, Francesca,
Testoni, Nicoletta,
Baccarani, Michele,
Manzoli, Lucia,
Martinelli, Giovanni,
Martelli, Alberto,
Cocco, Lucio
(Bologna, Italy) |
| |
| 18:00-19:15 |
|
EFFECT OF AZACITIDINE (AZA) ON TRANSFUSION INDEPENDENCE (TI) AND OVERALL SURVIVAL (OS) IN PATIENTS (PTS) WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)
| 0813 |
| Seymour, John,
Santini, Valeria,
Fenaux, Pierre,
Giagounidis, Aristoteles,
Sanz, Guillermo ,
List, Alan,
McKenzie, David,
Backstrom, Jay,
Beach, CL
(East Melbourne, Australia) |
| |
| 18:00-19:15 |
|
EVALUATION OF APOPTOTIC MOLECULAR MARKERS AND GENE METHYLATION STATUS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
| 0814 |
| CORTESAO, Emilia,
Gonçalves, Ana Cristina (P),
Sousa, Maria Isabel,
Moucho, Carlos,
Rito, Luis,
Magalhães, Emília,
Espadana, Ana Isabel,
Pereira, Maria Amélia,
Teixeira, Adriana,
Nascimento Costa, José,
Sarmento Ribeiro, Ana Bela
(Coimbra, Portugal) |
| |
|